The global respiratory diagnostics market, valued at US$ 5.85 billion in 2023, is forecasted to grow at a robust CAGR of 6.5%, reaching US$ ...
The following is a summary of “Multidisciplinary Center Care for Long COVID Syndrome–A Retrospective Cohort Study,” published in the January 2025 issue of Pulmonology by Bailey et al. Researchers ...
A study on bat genomes, involving Texas Tech University, discovered genetic adaptations that help bats resist viral ...
9h
The global respiratory diagnostics market, valued at US$ 5.85 billion in 2023, is forecasted to grow at a robust CAGR of 6.5%, reaching US$ 6.17 billion in 2024 and an impressive US$ 9.02 billion by ...
The global respiratory diagnostics market, valued at US$ 5.85 billion in 2023, is forecasted to grow at a robust CAGR of 6.5%, reaching US$ 6.17 billion in 2024 and an impressive US$ 9.02 billion by ...
Achieve Life Sciences, Inc. , a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, ...
Immunocompromised participants were much more likely to have received at least four doses of COVID-19 vaccine than their ...
Today the Coalition for Epidemic Preparedness Innovations (CEPI) announced an award of $5 million funding award to Ethris, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback